5327422026-01-012026-03-315327422026-03-315327422025-03-315327422025-04-012026-03-315327422026-01-012026-03-31in-capmkt:OtherExpenses1Member5327422025-04-012026-03-31in-capmkt:OtherExpenses1Member5327422026-03-31OtherNoncurrentFinancialAssetsDomain15327422026-03-31OtherNoncurrentAssetsDomain15327422026-03-31OtherCurrentFinancialAssetsDomain15327422026-03-31OtherCurrentAssetsDomain15327422026-03-31OtherCurrentFinancialLiabilitiesDomain15327422026-03-31OtherCurrentLiabilitiesDomain15327422026-01-012026-03-31RelatedPartyTransactionDomain15327422025-12-31RelatedPartyTransactionDomain15327422026-03-31RelatedPartyTransactionDomain15327422026-01-012026-03-31RelatedPartyTransactionDomain25327422025-12-31RelatedPartyTransactionDomain25327422026-03-31RelatedPartyTransactionDomain25327422026-01-012026-03-31RelatedPartyTransactionDomain35327422025-12-31RelatedPartyTransactionDomain35327422026-03-31RelatedPartyTransactionDomain35327422026-01-012026-03-31RelatedPartyTransactionDomain45327422025-12-31RelatedPartyTransactionDomain45327422026-03-31RelatedPartyTransactionDomain45327422026-01-012026-03-31RelatedPartyTransactionDomain55327422025-12-31RelatedPartyTransactionDomain55327422026-03-31RelatedPartyTransactionDomain55327422026-01-012026-03-31RelatedPartyTransactionDomain65327422025-12-31RelatedPartyTransactionDomain65327422026-03-31RelatedPartyTransactionDomain65327422026-01-012026-03-31RelatedPartyTransactionDomain75327422025-12-31RelatedPartyTransactionDomain75327422026-03-31RelatedPartyTransactionDomain75327422026-01-012026-03-31RelatedPartyTransactionDomain85327422025-12-31RelatedPartyTransactionDomain85327422026-03-31RelatedPartyTransactionDomain85327422026-01-012026-03-31RelatedPartyTransactionDomain95327422025-12-31RelatedPartyTransactionDomain95327422026-03-31RelatedPartyTransactionDomain95327422026-01-012026-03-31RelatedPartyTransactionDomain105327422025-12-31RelatedPartyTransactionDomain105327422026-03-31RelatedPartyTransactionDomain105327422026-01-012026-03-31RelatedPartyTransactionDomain115327422025-12-31RelatedPartyTransactionDomain115327422026-03-31RelatedPartyTransactionDomain115327422026-01-012026-03-31RelatedPartyTransactionDomain125327422025-12-31RelatedPartyTransactionDomain125327422026-03-31RelatedPartyTransactionDomain125327422026-01-012026-03-31RelatedPartyTransactionDomain135327422025-12-31RelatedPartyTransactionDomain135327422026-03-31RelatedPartyTransactionDomain135327422026-01-012026-03-31RelatedPartyTransactionDomain145327422025-12-31RelatedPartyTransactionDomain145327422026-03-31RelatedPartyTransactionDomain145327422026-01-012026-03-31RelatedPartyTransactionDomain155327422025-12-31RelatedPartyTransactionDomain155327422026-03-31RelatedPartyTransactionDomain155327422026-01-012026-03-31RelatedPartyTransactionDomain165327422025-12-31RelatedPartyTransactionDomain165327422026-03-31RelatedPartyTransactionDomain165327422026-01-012026-03-31RelatedPartyTransactionDomain175327422025-12-31RelatedPartyTransactionDomain175327422026-03-31RelatedPartyTransactionDomain175327422026-01-012026-03-31RelatedPartyTransactionDomain185327422025-12-31RelatedPartyTransactionDomain185327422026-03-31RelatedPartyTransactionDomain185327422026-01-012026-03-31RelatedPartyTransactionDomain195327422025-12-31RelatedPartyTransactionDomain195327422026-03-31RelatedPartyTransactionDomain195327422026-01-012026-03-31RelatedPartyTransactionDomain205327422025-12-31RelatedPartyTransactionDomain205327422026-03-31RelatedPartyTransactionDomain205327422026-01-012026-03-31RelatedPartyTransactionDomain215327422025-12-31RelatedPartyTransactionDomain215327422026-03-31RelatedPartyTransactionDomain215327422026-01-012026-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares532742PAUSHAKLTDNOTLISTEDINE111F01016PAUSHAK LIMITEDMain BoardEquity2025-04-012026-03-312026-05-052026-04-27INRLakhsQuarterlyFourth quarterSingle segmentSpeciality Chemicals and Intermediates2026-05-0516:30:002026-05-0517:20:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2025-01-30https://www.paushak.com/wp-content/uploads/2025/06/Policy-on-dealing-with-Related-Party-Transaction.pdffalsefalseThere is no default is payment of interest or principal amount.2026-01-012026-03-31AuditedStandalone551444000820640006335080001902750000-85266000925550001016600079018000186556000473304000160204000016020400036253000-11440003510900001250950000000125095000-772680004782700012328500055.075.07005.075.070.00190.11861. The above results were audited by the Statutory Auditors, recommended by the Audit Committee and approved by the Board of Directors of the Company. <BR> <BR> 2. The Company is engaged in the business of Speciality Chemicals only and therefore, there is only one reportable segment. <BR> <BR> 3. The Board has recommended dividend on Equity Shares at Rs.2.5/- per share i.e.50% for the year ended on 31st March, 2026. (P.Y. Rs. 20/- per share i.e. 200%). <BR> <BR> 4. The Government of India has notified the implementation of four new Labour Codes on 21st November, 2025, by consolidating and rationalizing 29 existing labour laws. The Company has provisionally estimated the financial implications thereof and has made additional provision under 'Employee benefit expense' for INR 101.07 lacs in the financial results for the quarter ended on 31st December, 2025. This will be reviewed and revised, if required once Central / State Rules are notified by the Government on all aspects of the Codes. <BR> <BR> 5. The Earning Per Share in respect of the previous quarters/year has been restated to give effect of sub-division of shares and allotment of bonus shares in line with requirement of IND AS 33 'Earnings per share'. <BR> <BR> 6. The figures for quarter ended 31st March 2026 are the balancing figures between the audited figures in respect of full financial year ended 31st March 2026 and year to date unaudited figures up to the third quarter ended 31st December 2025. <BR> <BR> 7. The previous quarters'/year's figures have been regrouped/rearranged wherever necessary to make it comparable with the current quarter/period.2025-04-012026-03-31AuditedStandalone218601000012108600023070960005723930000-1147290003975610001114000021383900072277900018029830005041130000504113000349550007590500011086000003932530000000393253000-752770003179760001232850005383634700015.9515.950015.9515.950.00190.1186The Company does not have any principal repayment in the FY 2025-26, hence this ratio is not applicable.Other expenses186556000Other expenses7227790003766272000261690000038100012239340000287530001252687000177200052828020003664290002734520005486410001830007182000065110008359690000114208000131660600065994080001232850004787928000491121300049112130006000000006000000002020400038148200032061000103374700016939900021072000285597000306669000140849000616917000115200001067800012003000333000065444800016881950006599408000Other Financial Assets28753000Other Non - Current Assets1772000- Other Financial Assets6511000Other current assets114208000- Other Financial Liabilities140849000Other Current Liabilities1152000010698000-150042000102000022368000041000-134900001061230000-9420000213839000042610004192000-53500000-336100038060003107800008240000-795400000-118500008579500058990800000053375000053653300000-1208690000000040300008809070000000000000572700000000038060003631800000-951895000000000005192970000060505000433890000041540300041000041000142000183000973200088980006753600066379000-77268000-75277000Paushak Ltd.******Alembic Ltd.******Promoters GroupPurchase of goods or services118000000No additional Remarks446000000Purchase of servicesPaushak Ltd.******Alembic Ltd.******Promoters GroupPurchase of goods or services118000000No additional Remarks700000Purchase of goodsPaushak Ltd.******Alembic Ltd.******Promoters GroupSale of fixed assets59000000No additional Remarks6600000Paushak Ltd.******Alembic Pharmaceuticals Ltd.******Promoters GroupSale of goods or services118000000No additional Remarks2564500070050000Paushak Ltd.******Alembic Pharmaceuticals Ltd.******Promoters GroupAny other transactionReimbursement of Expenses9551000No additional Remarks513900001612000Paushak Ltd.******Ms. Yera Amin******Close Member of KMPPurchase of goods or services3540000No additional Remarks177000000Paushak Ltd.******Ms. Shreya Mukharji******Close Member of KMPPurchase of goods or services1770000No additional Remarks59000000Paushak Ltd.******Alembic City Ltd.******Promoters GroupPurchase of goods or services1949000No additional Remarks97500000Paushak Ltd.******Alembic City Ltd.******Promoters GroupAny other transactionReimbursement of Expenses657000No additional Remarks31100000Paushak Ltd.******Alembic City Ltd.******Promoters GroupAny other transactionDeposit placed0No additional Remarks0413000413000Paushak Ltd.******Shreno Engineering Ltd.******Promoters GroupPurchase of fixed assets118000000No additional Remarks16140009280000Paushak Ltd.******Nirayu Pvt. Ltd.******ParentInvestment80000000Not Applicable-80000000829600000688103000Transaction during the year for Rs. 800 Lacs pertains to redemption of preference shares by Nirayu Pvt. Ltd.Paushak Ltd.******Mr. Udit Amin******PromotersAny other transactionCommission to Non Executive Director13885000No additional Remarks4500000900000013500000Commission to Non-Executive Director represents proviosion made during the period in accordance with overall limits approved by shareholders. (Not exceeding 3% of the profits of the Company computed under Section 198 of the Companies, Act, 2013)Paushak Ltd.******Mr. Udit Amin******PromotersAny other transactionDirector's sitting fees190000No additional Remarks19000000Sitting fees paid to Directors is within the limits prescribed under the Companies Act, 2013 and as approved by the Board of Directors.Paushak Ltd.******Mr. Chirayu Amin******PromotersAny other transactionDirector's sitting fees160000No additional Remarks16000000Sitting fees paid to Directors is within the limits prescribed under the Companies Act, 2013 and as approved by the Board of Directors.Paushak Ltd.******Paushak Ltd PF Trust******Post Employment Benefit PlanAny other transactionContribution to Provident Fund30503000No additional Remarks158830000960000Paushak Ltd.******Alembic CSR Foundation******Other related partyAny other transactionCSR contribution10583000No additional Remarks529100000Paushak Ltd.******Nirayu Pvt. Ltd.******ParentAny other transactionInterest accounted on effective interest method14794000No additional Remarks1479400000Transaction during the year pertains to interest income accounted based on EIR on preference shares.Paushak Ltd.******Alembic Ltd.******Promoters GroupInvestment0Not Applicable0152000108000There are no transactions during the period.Paushak Ltd.******Alembic Pharmaceuticals Ltd.******Promoters GroupInvestment0Not Applicable0771000568000There are no transactions during the period.Paushak Ltd.******Shreno Ltd.******Promoters GroupInvestment0Not Applicable0398061000459536000There are no transactions during the period.1395000AuditedtrueCNK & Associates LLPtrue2027-07-31